BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21638045)

  • 1. Insights into the permeability of drugs and drug-like molecules from MI-QSAR and HQSAR studies.
    Shinde RN; Srikanth K; Sobhia ME
    J Mol Model; 2012 Mar; 18(3):947-62. PubMed ID: 21638045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Caco-2 cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis.
    Kulkarni A; Han Y; Hopfinger AJ
    J Chem Inf Comput Sci; 2002; 42(2):331-42. PubMed ID: 11911703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis.
    Iyer M; Tseng YJ; Senese CL; Liu J; Hopfinger AJ
    Mol Pharm; 2007; 4(2):218-31. PubMed ID: 17397237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting MDCK cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis.
    Chen LL; Yao J; Yang JB; Yang J
    Acta Pharmacol Sin; 2005 Nov; 26(11):1322-33. PubMed ID: 16225754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined 4D-fingerprint and clustering based membrane-interaction QSAR analyses for constructing consensus Caco-2 cell permeation virtual screens.
    Santos-Filho OA; Hopfinger AJ
    J Pharm Sci; 2008 Jan; 97(1):566-83. PubMed ID: 17696143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting blood-brain barrier partitioning of organic molecules using membrane-interaction QSAR analysis.
    Iyer M; Mishra R; Han Y; Hopfinger AJ
    Pharm Res; 2002 Nov; 19(11):1611-21. PubMed ID: 12458666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR-based permeability model for drug-like compounds.
    Gozalbes R; Jacewicz M; Annand R; Tsaioun K; Pineda-Lucena A
    Bioorg Med Chem; 2011 Apr; 19(8):2615-24. PubMed ID: 21458999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hologram QSAR model for the prediction of human oral bioavailability.
    Moda TL; Montanari CA; Andricopulo AD
    Bioorg Med Chem; 2007 Dec; 15(24):7738-45. PubMed ID: 17870541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting permeability coefficient in ADMET evaluation by using different membranes-interaction QSAR.
    Liu J; Li Y; Pan D; Hopfinger AJ
    Int J Pharm; 2005 Nov; 304(1-2):115-23. PubMed ID: 16182478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MI-QSAR models for prediction of corneal permeability of organic compounds.
    Chen C; Yang J
    Acta Pharmacol Sin; 2006 Feb; 27(2):193-204. PubMed ID: 16412269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds.
    Waller CL
    J Chem Inf Comput Sci; 2004; 44(2):758-65. PubMed ID: 15032558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ensemble hologram quantitative structure activity relationship model of the chromatographic retention index of aldehydes and ketones].
    Lei B; Zang Y; Xue Z; Ge Y; Li W; Zhai Q; Jiao L
    Se Pu; 2021 Mar; 39(3):331-337. PubMed ID: 34227314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADME evaluation in drug discovery. 5. Correlation of Caco-2 permeation with simple molecular properties.
    Hou TJ; Zhang W; Xia K; Qiao XB; Xu XJ
    J Chem Inf Comput Sci; 2004; 44(5):1585-600. PubMed ID: 15446816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment-based and classical quantitative structure-activity relationships for a series of hydrazides as antituberculosis agents.
    Andrade CH; Salum Lde B; Castilho MS; Pasqualoto KF; Ferreira EI; Andricopulo AD
    Mol Divers; 2008 Feb; 12(1):47-59. PubMed ID: 18373208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
    Gajjar KA; Gajjar AK
    Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the relationship between cornea permeability and eye irritation using membrane-interaction QSAR analysis.
    Li Y; Liu J; Pan D; Hopfinger AJ
    Toxicol Sci; 2005 Dec; 88(2):434-46. PubMed ID: 16162848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CoMFA and HQSAR studies on 6,7-dimethoxy-4-pyrrolidylquinazoline derivatives as phosphodiesterase10A inhibitors.
    Kulkarni SS; Patel MR; Talele TT
    Bioorg Med Chem; 2008 Apr; 16(7):3675-86. PubMed ID: 18299198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
    Sainy J; Sharma R
    SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment-based QSAR: perspectives in drug design.
    Salum LB; Andricopulo AD
    Mol Divers; 2009 Aug; 13(3):277-85. PubMed ID: 19184499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
    Akamatsu M; Fujikawa M; Nakao K; Shimizu R
    Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.